Fair Trade Act to penalize unfair prescription business practices.

Published: 2000-10-30 11:18:00

Updated: 2000-10-30 11:18:00

The MOHW took the 5th talks with the KPA on Oct. 25 at the Korea Health and Industry Promotion Board and discussed 27 subjects raised by the KPA including the prohibition of prescription business collusion between medical institutes and pharmacies. In the talks they shared with the same view that...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK